DynaMed editorial team

DynaMed is a clinician-focused tool designed to facilitate efficient and evidence-based patient care. Rigorous, daily review of medical literature by physician and specialist staff ensures timely and objective analysis, synthesis and guidance. DynaMed includes drug content from Micromedex, Canadian and international guidelines, and clinical images. CMA members have access to DynaMed, a point-of-care tool, included with their membership ― a tool valued at US$399 a year.

mRNA vaccines for COVID-19 – how do they work?

Millions of people around the world are receiving an mRNA-based vaccine for COVID-19. The editorial team at DynaMed shares how they work.
Read
Antiviral monoclonal antibody therapy for COVID-19 – does it work?

Antiviral monoclonal antibody therapy is authorized for outpatients with mild-to-moderate COVID-19 at high risk for clinical progression. The DynaMed editorial team shares how this new therapy works.
Read
Five questions about COVID-19 vaccines answered

Seven different COVID-19 vaccines are authorized around the world. Read about availability, vaccine types, vaccine efficacy, variants and vaccination precautions from the DynaMed editorial team.
Read
Clinical research advancements you might have missed in 2020

While COVID-19 took much of the world’s attention in 2020, clinical research in other areas continued. The DynaMed editorial team has identified important new research findings in those areas.
Read
Answers to 10 questions your patients have been asking about COVID-19

Members of the DynaMed editorial team pulled together some evidence-based answers to ten questions patients are asking about COVID-19.
Read
10 things you need to know about COVID-19 now

The DynaMed editorial team answers 10 commonly asked clinical questions about COVID-19 using the latest evidence.
Read
Five research discoveries affecting clinical care for COVID-19

Read an update from the DynaMed Infectious Disease team about five research discoveries that have affected clinical care of patients with COVID-19 around the world.
Read
Answering physicians’ clinical questions about COVID-19

The DynaMed editorial team answers 10 frequently asked questions about SARS-CoV-2 using the latest evidence.
Read
Loading More...

DynaMed editorial team

mRNA vaccines for COVID-19 – how do they work?

Millions of people around the world are receiving an mRNA-based vaccine for COVID-19. The editorial team at DynaMed shares how they work.

Antiviral monoclonal antibody therapy for COVID-19 – does it work?

Antiviral monoclonal antibody therapy is authorized for outpatients with mild-to-moderate COVID-19 at high risk for clinical progression. The DynaMed editorial team shares how this new therapy works.

Five questions about COVID-19 vaccines answered

Seven different COVID-19 vaccines are authorized around the world. Read about availability, vaccine types, vaccine efficacy, variants and vaccination precautions from the DynaMed editorial team.

Clinical research advancements you might have missed in 2020

While COVID-19 took much of the world’s attention in 2020, clinical research in other areas continued. The DynaMed editorial team has identified important new research findings in those areas.

Answers to 10 questions your patients have been asking about COVID-19

Members of the DynaMed editorial team pulled together some evidence-based answers to ten questions patients are asking about COVID-19.

10 things you need to know about COVID-19 now

The DynaMed editorial team answers 10 commonly asked clinical questions about COVID-19 using the latest evidence.

Five research discoveries affecting clinical care for COVID-19

Read an update from the DynaMed Infectious Disease team about five research discoveries that have affected clinical care of patients with COVID-19 around the world.

Answering physicians’ clinical questions about COVID-19

The DynaMed editorial team answers 10 frequently asked questions about SARS-CoV-2 using the latest evidence.